26.08.2022 • News

Arxada Expands at Visp to Continue Supplying DSM

Swiss specialty chemicals company Arxada said it will invest 20 million Swiss francs to expand production at its Visp site following the extension of a long-term supply partnership with DSM.

Arxada supplies niacin and various other nutritional ingredients to DSM’s vitamin and aroma ingredients business in neighboring Visp-Lalden. The company will also make further investments to cut Visp’s carbon footprint so as to help meet both firms’ sustainability commitments.

“This significant new investment in our Visp facility secures the site’s long-term future, helping to fuel our future growth, and demonstrates our clear commitment to sustainability and reducing our carbon footprint,” said Antje Gerber, Arxada’s president, specialty products solutions.

Arxada did not give a start-up date for the expansion. The Basel-based firm said it had already made a “significant” investment at the site last year to reduce greenhouse gas emissions.

Author: Elaine Burridge, Freelance Journalist

©lichtmeister/Shutterstock
©lichtmeister/Shutterstock

Company

Logo:

Arxada AG


4052 Basel
Switzerland

Company contact







Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read